Enlarge / Pfizer headquarters in Manhattan on November 19, 2020. (credit: Getty | Anadolu Agency ) An antiviral pill developed by Pfizer reduced COVID-19 hospitalizations and deaths by about 89 percent in a trial involving 774 newly infected people at risk of developing severe disease. That’s according to a press release posted Friday by the […]
